US 8114394
Use of IL-1 antagonists to treat gout
granted A61KA61K31/195A61K31/216
Quick answer
US patent 8114394 (Use of IL-1 antagonists to treat gout) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/195, A61K31/216, A61K31/343, A61K31/4152